Purchase Order 75N91020P00006

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,260.00 on November 9, 2020, for biological and reagent material. Place of performance is Marshtonlon, Delaware. The order carries a firm fixed price and an ultimate completion date of December 30, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $13,570.50 on July 6, 2020, for drugs and biologicals, with completion on August 6, 2020. Work is performed at Marshtonlon, Delaware. The order carries firm fixed price terms with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. valued at $11,383.20 for a maintenance agreement, with an award date of October 31, 2017 and ultimate completion date of November 30, 2018. Performance is located in Bethesda, Maryland. The order is priced firm fixed price with no set-aside category.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $24,998.51 in scientific laboratory equipment on March 11, 2021, with an ultimate completion date of May 31, 2021. Performance takes place in Marshallton, Delaware. The order is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,260.00 on August 31, 2020, for biological and reagent material with a firm fixed price. Place of performance is Marshallton, Delaware, with an ultimate completion date of September 30, 2020. The order was not set-aside and reflects full and open competition.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $10,972.00 on September 8, 2017, with ultimate completion on October 23, 2017. Performance took place in Marshallton, Delaware. The order was firm fixed price with no set-aside. The source does not specify the procurement's scope or originating solicitation.</p>

The National Cancer Institute issued a purchase order to Agilent Technologies Inc. on October 31, 2018, with a firm fixed price of $11,890.80 and an ultimate completion date of October 31, 2019. Place of performance is Marshallton, Delaware. The order procures analytical laboratory instrumentation or associated consumables and maintenance services, consistent with Agilent's core product portfolio of gas chromatography–mass spectrometry systems, liquid chromatography–mass spectrometry...

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $17,948.50 on September 19, 2019, for drugs and biologicals, with ultimate completion on October 19, 2019. Place of performance is Bethesda, Maryland. The order uses firm fixed-price pricing with no set-aside category.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. valued at $16,259.00 on May 1, 2019, for drugs and biologicals, with ultimate completion on June 3, 2019. Place of performance is Marshtonville, Delaware. The order carries no set-aside designation and is priced on a firm fixed price basis.</p>

The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $12,904.00, with an award date of August 22, 2017 and ultimate completion on September 22, 2017. Performance takes place in Marshallton, Delaware. The order is a firm fixed price procurement for analytical laboratory equipment or consumables, consistent with Agilent's role as a supplier of gas chromatography-mass spectrometry systems, liquid chromatography-mass spectrometry equipment, and associated...